Terumo pays $2.6 billion for US blood-processing firm

Japanese firms continue on the M&A trail with Terumo entering a $2.6 billion deal to buy US blood-processing technologies company CaridianBCT from its Swedish owners.

Terumo Medical Corporation has bought CaridianBCT for $2.63 billion, in the latest of a series of cross-border acquisitions by Japanese healthcare firms.

CaridianBCT started life as the blood-related division of a Swedish company called Gambro, which was bought in 2006 by Investor AB, a Nordic-based industrial-holding and private-equity firm. A year later, it restructured Gambro into three separate companies, one of which was Colorado-based CaridianBCT.

In the...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: terumo | caridianbct | investor ab | ma | blood processing | finance | asia

Print Edition

FinanceAsia Print Edition